Clinical Trial Update: A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study from AstraZeneca compared Ticagrelor absorption using different tablet formulations in individuals with sickle cell disease; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED